Approval · Notice of Compliance 15352 · 2014
RAN-MEROPENEM: Notice of Compliance 15352
Issued February 27, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15352
- Date
- February 27, 2014
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- MERREM (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-MEROPENEM | 02421518 | Marketed |
| RAN-MEROPENEM | 02421526 | Marketed |